• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RGT 0.00% 32.0¢

ARGENT BIOPHARMA LIMITED - Announcements

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

Announcements


Filters [Clear]
  • Price Sensitive: Yes
RGT Preliminary Final ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 489.16KB
RGT Voluntary Delisting from ASXPRICE SENSITIVE15/08/24 download Created with Sketch. 255.33KB
RGT Trading HaltPRICE SENSITIVE13/08/24 download Created with Sketch. 564.56KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/07/24 download Created with Sketch. 424.53KB
RGT Placing to Raise US$2,000,000PRICE SENSITIVE16/07/24 download Created with Sketch. 197.52KB
RGT Trading HaltPRICE SENSITIVE12/07/24 download Created with Sketch. 561.6KB
RGT Placing to Raise US$500,000PRICE SENSITIVE01/07/24 download Created with Sketch. 245.06KB
RGT Trading HaltPRICE SENSITIVE28/06/24 download Created with Sketch. 236.73KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 448.09KB
RGT Half Year AccountsPRICE SENSITIVE29/02/24 download Created with Sketch. 1.01MB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 485.92KB
RGT Company Update & Capital RaisingPRICE SENSITIVE22/12/23 download Created with Sketch. 252.55KB
RGT Retraction of StatementPRICE SENSITIVE21/12/23 download Created with Sketch. 198.15KB
RGT Pause in tradingPRICE SENSITIVE21/12/23 download Created with Sketch. 116.81KB
RGT MGC Secures US$7.9 Million in Firm CommitmentsPRICE SENSITIVE01/11/23 download Created with Sketch. 270.27KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/10/23 download Created with Sketch. 581.83KB
RGT Trading HaltPRICE SENSITIVE30/10/23 download Created with Sketch. 581KB
RGT Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 642.18KB
RGT Share Purchase Plan ClosedPRICE SENSITIVE30/08/23 download Created with Sketch. 227.06KB
RGT Pre-clinical Trial Results on CimetrAPRICE SENSITIVE14/08/23 download Created with Sketch. 279.17KB
RGT MGC Pharma Launches Share Purchase PlanPRICE SENSITIVE01/08/23 download Created with Sketch. 218.64KB
RGT MGC receives permission for first import of PsilocybinPRICE SENSITIVE31/07/23 download Created with Sketch. 256.18KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/07/23 download Created with Sketch. 782.69KB
RGT Commitments Received for GBP 0.7mPRICE SENSITIVE14/07/23 download Created with Sketch. 482.3KB
RGT AMC Places Second Order of ArtemiC for US$1MPRICE SENSITIVE07/07/23 download Created with Sketch. 242.11KB
RGT Malta Production Facility Receives EU-GMP ApprovalPRICE SENSITIVE02/05/23 download Created with Sketch. 252.9KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 598.45KB
RGT Fundraise closed raising up to a total of GBP 2.09mPRICE SENSITIVE13/04/23 download Created with Sketch. 352.17KB
RGT CannEpil now available by Named Patient Request in UKPRICE SENSITIVE11/04/23 download Created with Sketch. 282.24KB
RGT Funding Commitments Received for GBP 1.8mPRICE SENSITIVE11/04/23 download Created with Sketch. 580.07KB
RGT Trading HaltPRICE SENSITIVE11/04/23 download Created with Sketch. 583.48KB
RGT MGC Receive Permission for Psilocybin Research & DevelopmentPRICE SENSITIVE03/04/23 download Created with Sketch. 243.11KB
RGT ArtemiC Listed as OTC Drug in USA, AMC Places US$2m OrderPRICE SENSITIVE21/03/23 download Created with Sketch. 281.01KB
RGT Completion of CimetrA Mechanism of Action studyPRICE SENSITIVE07/03/23 download Created with Sketch. 324.77KB
RGT Half Year AccountsPRICE SENSITIVE28/02/23 download Created with Sketch. 762.24KB
RGT Provision of US$600,000 Funding and change of CFOPRICE SENSITIVE03/02/23 download Created with Sketch. 203.44KB
RGT Refinancing and Extension to Convertible Security AgreementsPRICE SENSITIVE02/02/23 download Created with Sketch. 215.36KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/23 download Created with Sketch. 1.55MB
RGT Results of CimetrA bioanalytics pre-clinal trialPRICE SENSITIVE10/01/23 download Created with Sketch. 349.88KB
RGT Internal Costs Review Completed and Board ChangePRICE SENSITIVE03/01/23 download Created with Sketch. 249.35KB
RGT $800,000 of funding received through Mercer FacilityPRICE SENSITIVE23/12/22 download Created with Sketch. 235.46KB
RGT Completion of CimetrA Efficacy Pre-clinical TrialPRICE SENSITIVE07/12/22 download Created with Sketch. 224.62KB
RGT US$1,000,000 ArtemiC order delivered to US partner, AMCPRICE SENSITIVE05/12/22 download Created with Sketch. 269.38KB
RGT Publication of Peer Reviewed Glioblastoma ResearchPRICE SENSITIVE02/12/22 download Created with Sketch. 363.02KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 397.63KB
RGT Long COVID study ResultsPRICE SENSITIVE25/10/22 download Created with Sketch. 496.19KB
RGT Trading HaltPRICE SENSITIVE24/10/22 download Created with Sketch. 978.04KB
RGT Pause in TradingPRICE SENSITIVE24/10/22 download Created with Sketch. 116.1KB
RGT Operations UpdatePRICE SENSITIVE20/10/22 download Created with Sketch. 237.39KB
RGT Appointment of UK Corporate Advisor and Company UpdatePRICE SENSITIVE04/10/22 download Created with Sketch. 906.45KB
RGT TGA advertising Infringement NoticePRICE SENSITIVE28/09/22 download Created with Sketch. 169.23KB
RGT US$550,000 Convertible Note Facility FundingPRICE SENSITIVE23/09/22 download Created with Sketch. 216.97KB
RGT Interim Results - CimetrA Dosing Finding StudyPRICE SENSITIVE21/09/22 download Created with Sketch. 280.99KB
RGT Preliminary Final ReportPRICE SENSITIVE01/09/22 download Created with Sketch. 514.78KB
RGT US$750,000 Convertible Note Facility FundingPRICE SENSITIVE25/08/22 download Created with Sketch. 198.01KB
RGT AMC Holdings Inc places US$1 million ArtemiC orderPRICE SENSITIVE17/08/22 download Created with Sketch. 260.59KB
RGT Study Results - Effects of CannEpil on driving performancePRICE SENSITIVE15/08/22 download Created with Sketch. 915.06KB
RGT US$1.2M Tranche 1 Funding Recevied from MercerPRICE SENSITIVE03/08/22 download Created with Sketch. 206.13KB
RGT US$10M Financing Agreement signed with US Financier/InvestorPRICE SENSITIVE29/07/22 download Created with Sketch. 247.08KB
RGT Strategic Acquisition of 40% interest in ZAM Software LtdPRICE SENSITIVE28/07/22 download Created with Sketch. 241.87KB
RGT Amended June Quarterly Reports (amended App. 4C)PRICE SENSITIVE25/07/22 download Created with Sketch. 333KB
RGT June Quarter Activities and Cash Flow ReportPRICE SENSITIVE25/07/22 download Created with Sketch. 332.89KB
RGT Long COVID Study Results for ArtemiC SupportPRICE SENSITIVE14/07/22 download Created with Sketch. 391.7KB
RGT Approvals received for South African CimetrA Clinical TrialPRICE SENSITIVE08/07/22 download Created with Sketch. 249.52KB
RGT CimetrA anti-inflammatory pre-clinical study resultsPRICE SENSITIVE27/06/22 download Created with Sketch. 1.11MB
RGT Glioblastoma pre-clinical trial resultsPRICE SENSITIVE16/06/22 download Created with Sketch. 1.14MB
RGT Cognicann Clinical Trial ResultsPRICE SENSITIVE06/06/22 download Created with Sketch. 348.51KB
RGT Response to ASX Aware QueryPRICE SENSITIVE18/05/22 download Created with Sketch. 1.18MB
RGT Patent Granted for CannEpiL SNEDDSPRICE SENSITIVE10/05/22 download Created with Sketch. 283.84KB
RGT March 2022 Quarterly Activity and Cash Flow ReportsPRICE SENSITIVE29/04/22 download Created with Sketch. 1.16MB
RGT Patent Granted for CimetrAPRICE SENSITIVE21/04/22 download Created with Sketch. 1012.55KB
RGT Sciensus Rare EU & UK Sales and Distribution AgreementPRICE SENSITIVE05/04/22 download Created with Sketch. 927.81KB
RGT Half Yearly Report and AccountsPRICE SENSITIVE01/03/22 download Created with Sketch. 901.72KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 1.8MB
RGT Response to ASX QueryPRICE SENSITIVE12/01/22 download Created with Sketch. 1.37MB
RGT ArtemiC receives Indian importation and sales approvalPRICE SENSITIVE07/01/22 download Created with Sketch. 959.91KB
RGT ArtemiC Long COVID Syndrome Clinical Study CommencedPRICE SENSITIVE21/12/21 download Created with Sketch. 1.09MB
RGT UK Capital Raising CompletedPRICE SENSITIVE01/12/21 download Created with Sketch. 259.96KB
RGT Trading HaltPRICE SENSITIVE30/11/21 download Created with Sketch. 1.16MB
RGT Production Completed of A$1M ArtemiC Order from SPCPRICE SENSITIVE25/11/21 download Created with Sketch. 859.79KB
RGT US Supply and Distribution Agreement UpdatePRICE SENSITIVE23/11/21 download Created with Sketch. 934.88KB
RGT MALTA CIMETRA PRODUCTION FACILITY UPDATEPRICE SENSITIVE03/11/21 download Created with Sketch. 245.97KB
RGT CIMETRA DOSE FINDING STUDY APPROVALPRICE SENSITIVE02/11/21 download Created with Sketch. 281.87KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE26/10/21 download Created with Sketch. 1.93MB
RGT Response to ASX Query LetterPRICE SENSITIVE15/10/21 download Created with Sketch. 712.18KB
RGT AMC INC. PLACES US$3M CIMETRA PURCHASE ORDERPRICE SENSITIVE07/10/21 download Created with Sketch. 952.83KB
RGT FIRST ORDER RECEIVED UNDER US SUPPLY AGREEMENTPRICE SENSITIVE30/09/21 download Created with Sketch. 229.98KB
RGT ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATEPRICE SENSITIVE16/09/21 download Created with Sketch. 311.79KB
RGT UK IMPORT PERMIT GRANTED FOR CANNEPILPRICE SENSITIVE14/09/21 download Created with Sketch. 1.04MB
RGT CIMETRA IMPORT APPROVAL GRANTED FOR INDIAPRICE SENSITIVE03/09/21 download Created with Sketch. 261.97KB
RGT Preliminary Final ReportPRICE SENSITIVE01/09/21 download Created with Sketch. 558.5KB
RGT MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENTPRICE SENSITIVE27/08/21 download Created with Sketch. 331.6KB
RGT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/07/21 download Created with Sketch. 1.12MB
RGT Response to ASX Query LetterPRICE SENSITIVE20/07/21 download Created with Sketch. 695.84KB
RGT PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEMPRICE SENSITIVE15/07/21 download Created with Sketch. 268.36KB
RGT 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIALPRICE SENSITIVE13/07/21 download Created with Sketch. 949.02KB
RGT CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELANDPRICE SENSITIVE15/06/21 download Created with Sketch. 267.63KB
RGT MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATEPRICE SENSITIVE25/05/21 download Created with Sketch. 207.37KB
RGT CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICEPRICE SENSITIVE18/05/21 download Created with Sketch. 220.44KB
RGT FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENTPRICE SENSITIVE07/05/21 download Created with Sketch. 359.71KB
RGT Preliminary Final Report
30/08/24PRICE SENSITIVE download Created with Sketch. 489.16KB
RGT Voluntary Delisting from ASX
15/08/24PRICE SENSITIVE download Created with Sketch. 255.33KB
RGT Trading Halt
13/08/24PRICE SENSITIVE download Created with Sketch. 564.56KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/07/24PRICE SENSITIVE download Created with Sketch. 424.53KB
RGT Placing to Raise US$2,000,000
16/07/24PRICE SENSITIVE download Created with Sketch. 197.52KB
RGT Trading Halt
12/07/24PRICE SENSITIVE download Created with Sketch. 561.6KB
RGT Placing to Raise US$500,000
01/07/24PRICE SENSITIVE download Created with Sketch. 245.06KB
RGT Trading Halt
28/06/24PRICE SENSITIVE download Created with Sketch. 236.73KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 448.09KB
RGT Half Year Accounts
29/02/24PRICE SENSITIVE download Created with Sketch. 1.01MB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 485.92KB
RGT Company Update & Capital Raising
22/12/23PRICE SENSITIVE download Created with Sketch. 252.55KB
RGT Retraction of Statement
21/12/23PRICE SENSITIVE download Created with Sketch. 198.15KB
RGT Pause in trading
21/12/23PRICE SENSITIVE download Created with Sketch. 116.81KB
RGT MGC Secures US$7.9 Million in Firm Commitments
01/11/23PRICE SENSITIVE download Created with Sketch. 270.27KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23PRICE SENSITIVE download Created with Sketch. 581.83KB
RGT Trading Halt
30/10/23PRICE SENSITIVE download Created with Sketch. 581KB
RGT Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 642.18KB
RGT Share Purchase Plan Closed
30/08/23PRICE SENSITIVE download Created with Sketch. 227.06KB
RGT Pre-clinical Trial Results on CimetrA
14/08/23PRICE SENSITIVE download Created with Sketch. 279.17KB
RGT MGC Pharma Launches Share Purchase Plan
01/08/23PRICE SENSITIVE download Created with Sketch. 218.64KB
RGT MGC receives permission for first import of Psilocybin
31/07/23PRICE SENSITIVE download Created with Sketch. 256.18KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23PRICE SENSITIVE download Created with Sketch. 782.69KB
RGT Commitments Received for GBP 0.7m
14/07/23PRICE SENSITIVE download Created with Sketch. 482.3KB
RGT AMC Places Second Order of ArtemiC for US$1M
07/07/23PRICE SENSITIVE download Created with Sketch. 242.11KB
RGT Malta Production Facility Receives EU-GMP Approval
02/05/23PRICE SENSITIVE download Created with Sketch. 252.9KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 598.45KB
RGT Fundraise closed raising up to a total of GBP 2.09m
13/04/23PRICE SENSITIVE download Created with Sketch. 352.17KB
RGT CannEpil now available by Named Patient Request in UK
11/04/23PRICE SENSITIVE download Created with Sketch. 282.24KB
RGT Funding Commitments Received for GBP 1.8m
11/04/23PRICE SENSITIVE download Created with Sketch. 580.07KB
RGT Trading Halt
11/04/23PRICE SENSITIVE download Created with Sketch. 583.48KB
RGT MGC Receive Permission for Psilocybin Research & Development
03/04/23PRICE SENSITIVE download Created with Sketch. 243.11KB
RGT ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
21/03/23PRICE SENSITIVE download Created with Sketch. 281.01KB
RGT Completion of CimetrA Mechanism of Action study
07/03/23PRICE SENSITIVE download Created with Sketch. 324.77KB
RGT Half Year Accounts
28/02/23PRICE SENSITIVE download Created with Sketch. 762.24KB
RGT Provision of US$600,000 Funding and change of CFO
03/02/23PRICE SENSITIVE download Created with Sketch. 203.44KB
RGT Refinancing and Extension to Convertible Security Agreements
02/02/23PRICE SENSITIVE download Created with Sketch. 215.36KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23PRICE SENSITIVE download Created with Sketch. 1.55MB
RGT Results of CimetrA bioanalytics pre-clinal trial
10/01/23PRICE SENSITIVE download Created with Sketch. 349.88KB
RGT Internal Costs Review Completed and Board Change
03/01/23PRICE SENSITIVE download Created with Sketch. 249.35KB
RGT $800,000 of funding received through Mercer Facility
23/12/22PRICE SENSITIVE download Created with Sketch. 235.46KB
RGT Completion of CimetrA Efficacy Pre-clinical Trial
07/12/22PRICE SENSITIVE download Created with Sketch. 224.62KB
RGT US$1,000,000 ArtemiC order delivered to US partner, AMC
05/12/22PRICE SENSITIVE download Created with Sketch. 269.38KB
RGT Publication of Peer Reviewed Glioblastoma Research
02/12/22PRICE SENSITIVE download Created with Sketch. 363.02KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 397.63KB
RGT Long COVID study Results
25/10/22PRICE SENSITIVE download Created with Sketch. 496.19KB
RGT Trading Halt
24/10/22PRICE SENSITIVE download Created with Sketch. 978.04KB
RGT Pause in Trading
24/10/22PRICE SENSITIVE download Created with Sketch. 116.1KB
RGT Operations Update
20/10/22PRICE SENSITIVE download Created with Sketch. 237.39KB
RGT Appointment of UK Corporate Advisor and Company Update
04/10/22PRICE SENSITIVE download Created with Sketch. 906.45KB
RGT TGA advertising Infringement Notice
28/09/22PRICE SENSITIVE download Created with Sketch. 169.23KB
RGT US$550,000 Convertible Note Facility Funding
23/09/22PRICE SENSITIVE download Created with Sketch. 216.97KB
RGT Interim Results - CimetrA Dosing Finding Study
21/09/22PRICE SENSITIVE download Created with Sketch. 280.99KB
RGT Preliminary Final Report
01/09/22PRICE SENSITIVE download Created with Sketch. 514.78KB
RGT US$750,000 Convertible Note Facility Funding
25/08/22PRICE SENSITIVE download Created with Sketch. 198.01KB
RGT AMC Holdings Inc places US$1 million ArtemiC order
17/08/22PRICE SENSITIVE download Created with Sketch. 260.59KB
RGT Study Results - Effects of CannEpil on driving performance
15/08/22PRICE SENSITIVE download Created with Sketch. 915.06KB
RGT US$1.2M Tranche 1 Funding Recevied from Mercer
03/08/22PRICE SENSITIVE download Created with Sketch. 206.13KB
RGT US$10M Financing Agreement signed with US Financier/Investor
29/07/22PRICE SENSITIVE download Created with Sketch. 247.08KB
RGT Strategic Acquisition of 40% interest in ZAM Software Ltd
28/07/22PRICE SENSITIVE download Created with Sketch. 241.87KB
RGT Amended June Quarterly Reports (amended App. 4C)
25/07/22PRICE SENSITIVE download Created with Sketch. 333KB
RGT June Quarter Activities and Cash Flow Report
25/07/22PRICE SENSITIVE download Created with Sketch. 332.89KB
RGT Long COVID Study Results for ArtemiC Support
14/07/22PRICE SENSITIVE download Created with Sketch. 391.7KB
RGT Approvals received for South African CimetrA Clinical Trial
08/07/22PRICE SENSITIVE download Created with Sketch. 249.52KB
RGT CimetrA anti-inflammatory pre-clinical study results
27/06/22PRICE SENSITIVE download Created with Sketch. 1.11MB
RGT Glioblastoma pre-clinical trial results
16/06/22PRICE SENSITIVE download Created with Sketch. 1.14MB
RGT Cognicann Clinical Trial Results
06/06/22PRICE SENSITIVE download Created with Sketch. 348.51KB
RGT Response to ASX Aware Query
18/05/22PRICE SENSITIVE download Created with Sketch. 1.18MB
RGT Patent Granted for CannEpiL SNEDDS
10/05/22PRICE SENSITIVE download Created with Sketch. 283.84KB
RGT March 2022 Quarterly Activity and Cash Flow Reports
29/04/22PRICE SENSITIVE download Created with Sketch. 1.16MB
RGT Patent Granted for CimetrA
21/04/22PRICE SENSITIVE download Created with Sketch. 1012.55KB
RGT Sciensus Rare EU & UK Sales and Distribution Agreement
05/04/22PRICE SENSITIVE download Created with Sketch. 927.81KB
RGT Half Yearly Report and Accounts
01/03/22PRICE SENSITIVE download Created with Sketch. 901.72KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 1.8MB
RGT Response to ASX Query
12/01/22PRICE SENSITIVE download Created with Sketch. 1.37MB
RGT ArtemiC receives Indian importation and sales approval
07/01/22PRICE SENSITIVE download Created with Sketch. 959.91KB
RGT ArtemiC Long COVID Syndrome Clinical Study Commenced
21/12/21PRICE SENSITIVE download Created with Sketch. 1.09MB
RGT UK Capital Raising Completed
01/12/21PRICE SENSITIVE download Created with Sketch. 259.96KB
RGT Trading Halt
30/11/21PRICE SENSITIVE download Created with Sketch. 1.16MB
RGT Production Completed of A$1M ArtemiC Order from SPC
25/11/21PRICE SENSITIVE download Created with Sketch. 859.79KB
RGT US Supply and Distribution Agreement Update
23/11/21PRICE SENSITIVE download Created with Sketch. 934.88KB
RGT MALTA CIMETRA PRODUCTION FACILITY UPDATE
03/11/21PRICE SENSITIVE download Created with Sketch. 245.97KB
RGT CIMETRA DOSE FINDING STUDY APPROVAL
02/11/21PRICE SENSITIVE download Created with Sketch. 281.87KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
26/10/21PRICE SENSITIVE download Created with Sketch. 1.93MB
RGT Response to ASX Query Letter
15/10/21PRICE SENSITIVE download Created with Sketch. 712.18KB
RGT AMC INC. PLACES US$3M CIMETRA PURCHASE ORDER
07/10/21PRICE SENSITIVE download Created with Sketch. 952.83KB
RGT FIRST ORDER RECEIVED UNDER US SUPPLY AGREEMENT
30/09/21PRICE SENSITIVE download Created with Sketch. 229.98KB
RGT ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATE
16/09/21PRICE SENSITIVE download Created with Sketch. 311.79KB
RGT UK IMPORT PERMIT GRANTED FOR CANNEPIL
14/09/21PRICE SENSITIVE download Created with Sketch. 1.04MB
RGT CIMETRA IMPORT APPROVAL GRANTED FOR INDIA
03/09/21PRICE SENSITIVE download Created with Sketch. 261.97KB
RGT Preliminary Final Report
01/09/21PRICE SENSITIVE download Created with Sketch. 558.5KB
RGT MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT
27/08/21PRICE SENSITIVE download Created with Sketch. 331.6KB
RGT Quarterly Activities/Appendix 4C Cash Flow Report
27/07/21PRICE SENSITIVE download Created with Sketch. 1.12MB
RGT Response to ASX Query Letter
20/07/21PRICE SENSITIVE download Created with Sketch. 695.84KB
RGT PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEM
15/07/21PRICE SENSITIVE download Created with Sketch. 268.36KB
RGT 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL
13/07/21PRICE SENSITIVE download Created with Sketch. 949.02KB
RGT CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELAND
15/06/21PRICE SENSITIVE download Created with Sketch. 267.63KB
RGT MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE
25/05/21PRICE SENSITIVE download Created with Sketch. 207.37KB
RGT CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE
18/05/21PRICE SENSITIVE download Created with Sketch. 220.44KB
RGT FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENT
07/05/21PRICE SENSITIVE download Created with Sketch. 359.71KB
(20min delay)
Last
32.0¢
Change
0.000(0.00%)
Mkt cap ! $15.48M
Open High Low Value Volume
32.0¢ 32.0¢ 32.0¢ $6.948K 21.71K

Buyers (Bids)

No. Vol. Price($)
1 1666 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 1000 1
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.